110 related articles for article (PubMed ID: 10631755)
1. Multiple emulsions containing rifampicin.
Khopade AJ; Jain NK
Pharmazie; 1999 Dec; 54(12):915-9. PubMed ID: 10631755
[TBL] [Abstract][Full Text] [Related]
2. A stable multiple emulsion system bearing isoniazid: preparation and characterization.
Khopade AJ; Jain NK
Drug Dev Ind Pharm; 1998 Mar; 24(3):289-93. PubMed ID: 9876587
[TBL] [Abstract][Full Text] [Related]
3. Potential of nanoemulsions for intravenous delivery of rifampicin.
Ahmed M; Ramadan W; Rambhu D; Shakeel F
Pharmazie; 2008 Nov; 63(11):806-11. PubMed ID: 19069240
[TBL] [Abstract][Full Text] [Related]
4. Multiple emulsion based systems for prolonged delivery of rifampicin: in vitro and in vivo characterization.
Nakhare S; Vyas SP
Pharmazie; 1997 Mar; 52(3):224-6. PubMed ID: 9109169
[TBL] [Abstract][Full Text] [Related]
5. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
[TBL] [Abstract][Full Text] [Related]
6. Targeting of multiple emulsions to the lungs.
Khopade AJ; Mahadik KR; Jain NK
Pharmazie; 1996 Aug; 51(8):558-62. PubMed ID: 8794466
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in-vivo evaluation of a cosmetic multiple emulsion containing vitamin C and wheat protein.
Akhtar N; Yazan Y
Pak J Pharm Sci; 2008 Jan; 21(1):45-50. PubMed ID: 18166519
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier.
Vasiljevic D; Parojcic J; Primorac M; Vuleta G
Int J Pharm; 2006 Feb; 309(1-2):171-7. PubMed ID: 16406403
[TBL] [Abstract][Full Text] [Related]
9. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Tween based microemulsion in the presence of TB drug rifampicin.
Mehta SK; Kaur G; Bhasin KK
Colloids Surf B Biointerfaces; 2007 Oct; 60(1):95-104. PubMed ID: 17646089
[TBL] [Abstract][Full Text] [Related]
11. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products.
Singh S; Mohan B
Int J Tuberc Lung Dis; 2003 Mar; 7(3):298-303. PubMed ID: 12661847
[TBL] [Abstract][Full Text] [Related]
12. Development and bioavailability assessment of ramipril nanoemulsion formulation.
Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
[TBL] [Abstract][Full Text] [Related]
13. Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa.
McIlleron H; Wash P; Burger A; Folb P; Smith P
Int J Tuberc Lung Dis; 2002 Apr; 6(4):356-61. PubMed ID: 11936746
[TBL] [Abstract][Full Text] [Related]
14. Prolonged release of rifampicin from multiple w/o/w emulsion systems.
Nakhare S; Vyas SP
J Microencapsul; 1995; 12(4):409-15. PubMed ID: 8583315
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro evaluation of a cosmetic emulsion from almond oil.
Akhtar N; Ahmad M; - G; Masood MI; Aleem M
Pak J Pharm Sci; 2008 Oct; 21(4):430-7. PubMed ID: 18930867
[TBL] [Abstract][Full Text] [Related]
16. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.
Ashokraj Y; Singh I; Kaur KJ; Kohli G; Bhade SR; Varma MV; Kaul CL; Panchagnula R
Int J Tuberc Lung Dis; 2005 Jul; 9(7):791-6. PubMed ID: 16013776
[TBL] [Abstract][Full Text] [Related]
18. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
Qurrat-ul-Ain ; Sharma S; Khuller GK; Garg SK
J Antimicrob Chemother; 2003 Apr; 51(4):931-8. PubMed ID: 12654730
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
[TBL] [Abstract][Full Text] [Related]
20. Emulsification mechanism and storage instabilities of hydrocarbon-in-water sub-micron emulsions stabilised with Tweens (20 and 80), Brij 96v and sucrose monoesters.
Henry JV; Fryer PJ; Frith WJ; Norton IT
J Colloid Interface Sci; 2009 Oct; 338(1):201-6. PubMed ID: 19589533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
